Loading...
Chemical structure of CBP-IN-1

GC34517

CBP-IN-1

Also known as (6S)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one

CBP-IN-1 (CCS1477) is an orally active, potent, and selective inhibitor of the p300/CBP bromodomain· CBP-IN-1 binds to p300 and CBP with Kd values of 1·3 and 1·7 nM, respectively, and with 170/130-fold selectivity compared with BRD4 with a Kd of 222 nM· CCS1477 inhibits cell proliferation in prostate cancer cell lines and decreases androgen receptor (AR)- and C-MYC-regulated gene expression

ChemicalCAS2222941-37-7MW534.6FormulaC30H32F2N4O3
CAS number
2222941-37-7
Molecular weight
534.6
Formula
C30H32F2N4O3
Solubility
DMSO： 100 mg/mL (187·06 mM)
InChIKey
SKDNDJWEBPQKCS-RIQBOWGZSA-N
Catalogue number
GC34517
Brand
GLPBIO
Computed properties PubChem CID 134457551 · XLogP 4.9 · TPSA 73.4 Ų · H-bond donors 0
XLogP
4.9
TPSA
73.4 Ų
H-bond donors
0
H-bond acceptors
7
Rotatable bonds
5
Heavy atoms
39

SMILES CC1=C(C(=NO1)C)C2=CC3=C(C=C2)N(C(=N3)[C@@H]4CCCC(=O)N4C5=CC(=C(C=C5)F)F)C6CCC(CC6)OC

Computed descriptors from PubChem (CID 134457551), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.